ALIPAY+
11.11.2022 03:22:38 CET | Business Wire | Press release
Alipay+, a suite of cross-border payment and marketing solutions, has supported global online merchant partners to serve over 100 million e-wallet users as they flock to take up the offers and benefits since the global Double 11 event kicked off on November 1.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221110006198/en/
Alipay+ is dedicated to bringing more exclusive offers and benefits from merchants around the world to hundreds of millions mobile-savvy consumers of its e-wallet partners. (Photo: Business Wire)
The consumers that participated in the event are mostly users of a dozen popular e-wallets from Southeast Asia, including GCash (The Philippines), TrueMoney (Thailand), Touch ’n Go eWallet (Malaysia), DANA (Indonesia) and Kakao Pay (South Korea). With Alipay+, these users can conveniently make cross-border payments with more than 1,000 global online merchants by using their local currency wallets on their respective platforms during the festival.
This year, e-wallet users could access coupons to exchange for free gifts and attractive deals offered by merchants listed on the Alipay+ Rewards section from their own payment apps. Consumers can also use direct payments at online checkout through e-wallets powered by Alipay+ solution, which ensures payments can be completed smoothly across the border, especially during the peak time of the festival.
From November 1 to 10, the number of online payment transactions via Alipay+ has recorded a significant growth of 40 percent compared to the previous year, while total e-wallet user payments through Alipay+ has experienced an increase of 30 percent. This is a testament to Alipay+’s increasing popularity and its capability to seamlessly execute cross-border payments and marketing.
In terms of transaction volume increase, the digital & entertainment sector saw the highest level of user participation this year, achieving over 200 percent growth in transactions volume this year, followed by the O2O and e-commerce sectors.
This year, the number of first-time merchant joiners account for about one third of the total global online merchants. During the first ten days of the festival, top-five first-time merchants on average recorded a five-time increase in the number of e-wallet users making payments and a three-time jump in total transaction volumes through Alipay+ compared with the previous month.
“We are excited to see the enthusiasm of consumers during November 11 mega sales this year as online shopping and digital payment have continued to evolve as the key channels for growth over the years,” said Daniel Marogy, Managing Director of foodpanda Philippines.
Introduced by Ant Group in 2020, Alipay+ is a suite of cross-border digital payment, marketing and merchant digitization solutions connecting global brands with mobile-savvy consumers worldwide, with an aim to enable businesses, especially small and medium-sized enterprises, to process a wide range of mobile payment methods and reach more than 1 billion regional and global consumers.
“Alipay+ is dedicated to bringing more exclusive offers and benefits from merchants around the world to hundreds of millions mobile-savvy consumers of our e-wallet partners,” said Jing Yin, General Manager of Acquiring Service and Global Strategic Accounts of Ant Group.
“Ant Group’s technology capabilities and know-how also ensure our merchants and wallet partners are able to process transactions smoothly during peak traffic time, such as the ongoing Alipay+ Double 11 Mega Deals and other promotional events,” he added.
The pandemic has notably accelerated digital adoption. The recent Global Findex data from the World Bank indicated that 8 percent of adults living in developing countries made their first digital payment after Covid-19 started. The research excluded China as the country already has high digital adoption rate and widespread use of mobile payment apps.
Home to the world’s fastest growing e-wallet user base, Southeast Asia is experiencing increasing digitization as 70 percent of the ASEAN population is now online, according to a recent HBSC research. Additionally, the Covid-19 pandemic led to a consumers’ rapid adoption of e-commerce and the demand for online transfer and contactless payments is not fading even as the world gradually recovers from the pandemic.
Over the past six months, Alipay+ has been making steady progress in markets including Southeast Asia, South Korea and Japan, connecting local and regional merchants with various digital payment methods. Last month, Alipay+ introduced three more Asia e-wallets to Singapore and now there are altogether six overseas e-wallets that can accept Alipay+. Alipay+ previously announced new merchant partnership in South Korea and Japan.
During the Singapore Fintech Festival concluded last week, Ant Group also announced that Alipay+’s global merchant coverage has more than doubled to over 2.5 million over the past six months.
About Alipay+
Alipay+ offers unified global mobile payment and marketing solutions that connect merchants with multiple e-wallets and payment methods from different countries and regions by collaborating with global partners. Consumers can conveniently use their preferred local payment methods while transacting seamlessly in a different market and be able to enjoy marketing offers by the merchants through Alipay+. Alipay+ is developed by Ant Group, the owner and operator of Alipay, one of the world’s leading digital open platforms.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221110006198/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States1.4.2026 13:30:00 CEST | Press release
-With this expansion, any variant that results in production of CFTR protein is now included in the indication for ALYFTREK and TRIKAFTA, reinforcing the impact these medicines have, regardless of the location of the variant in the CFTR protein--Approximately 800 more people with CF in the US are now eligible for a CFTR modulator for the first time- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved expanded use of ALYFTREK® (vanzacaftor/tezacaftor/ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 6 and older with a variant in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is either responsive based on clinical and/or in vitro data or results in production of CFTR protein. Additionally, the U.S. FDA has also expanded the indication statement for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in patients ages 2 and older. This label expansion was supported b
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer1.4.2026 13:30:00 CEST | Press release
A Landmark Registrational Study Aiming to Redefine Outcomes in MSS mCRC Which Represents Approximately 95% of Metastatic Colorectal Cancer CasesColorectal Cancer Has Become the Leading Cause of Cancer-related Death in Adults Under Age 50 Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that the first patient has been enrolled in the landmark global phase 3 BATTMAN (CO.33) trial (NCT07152821). This study is evaluating Agenus’ immunotherapy combination of botensilimab (BOT) plus balstilimab (BAL) versus best supportive care in patients with refractory, unresectable microsatellite stable (MSS)/mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC), a population long considered resistant to immunotherapy. This study is being conducted as a cooperative group trial led by the Canadian Cancer Trials Group (CCTG) from Canada and run across Canada, France, Australia and New Zealand. More than 100 sites will participate across the academic cooper
Klarna Agrees to $1.7 Billion Transaction Supporting up to $40B+ of Lending1.4.2026 13:19:00 CEST | Press release
Klarna, the global digital bank and flexible payments provider, has entered into a new capital efficiency transaction in the form of a Significant Risk Transfer (SRT), covering $1.7 billion-worth of Euro denominated loans and freeing up capital to support continued growth. Klarna has entered into a three-year agreement with a consortium led by Värde Partners. This is Klarna's sixth SRT transaction and improves how effectively Klarna deploys its capital on a global basis. "Our banking license is one of our biggest competitive advantages," said Niclas Neglén, Klarna's Chief Financial Officer. "This is our largest and most efficient SRT transaction to date. These transactions allow us to maximize every unit of capital to support our continued momentum." The transaction follows Klarna’s recently announced $2 billion facility supporting $17B of US Financing expansion. About Klarna Klarna is a global digital bank and flexible payments provider. With over 118 million global active Klarna user
Americhem Launches nDryve™: PFAS-Free In-Melt Technology Platform for Functional Fibers1.4.2026 13:00:00 CEST | Press release
Americhem, Inc., a global polymer solutions provider, today announced the launch of nDryve™, a PFAS-free, in-melt surface-modifying technology platform designed to deliver durable multi-fluid repellency against alcohol and other low-surface-energy fluids in fiber systems. As global regulations accelerate the phase-out of per- and polyfluoroalkyl substances (PFAS), manufacturers are under increasing pressure to maintain barrier performance without fluorinated chemistries. nDryve™ was developed to address this shift, offering a PFAS-free, in-melt alternative to conventional surface applied treatments. Engineered for Performance Without PFAS Often referred to as “forever chemicals,” PFAS have come under heightened regulatory scrutiny due to their persistence and potential environmental and health impacts. nDryve™ integrates directly into the polymer during melt processing, embedding surface-modifying functionality within the fiber matrix rather than relying on removable finishes. By engin
Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond1.4.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced a strategic partnership with Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical; HKEX: 00460). Under the agreement, both parties will combine Biocytogen’s leading fully human antibody discovery platform with Sihuan Pharmaceutical’s extensive capabilities in drug development, manufacturing, and commercialization. The collaboration will focus on advancing innovative therapies across multiple disease areas, including weight loss, leveraging complementary strengths to drive synergies and establish a long-term strategic partnership. Sihuan Pharmaceutical highly values the strength of Biocytogen’s technology platforms. In this collaboration, Biocytogen will leverage its integrated platforms, including proprietary target-humanized mouse models and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom